ARYx Therapeutics
(OTC) ARYX
ARYx Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$18.33M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-262.02 (Low)
Dividend
$0.00
Beta (Volatility)
-262.02 (Low)
Price
$0.00
Volume
3,090
Open
$0.00
Price
$0.00
Volume
3,090
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
-262.02 (Low)
Price
$0.00
Volume
3,090
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
ARYX News
ARYX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout ARYx Therapeutics
ARYX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-8%
Return on Assets
-3%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$0.00
Shares Outstanding
33.46M
Volume
3.09K
Short Interest
0.00%
Avg. Volume
0
Financials (TTM)
Gross Profit
$0.00
Operating Income
$31.24M
EBITDA
$30.06M
Operating Cash Flow
$34.97M
Capital Expenditure
$141.00K
Free Cash Flow
$35.11M
Cash & ST Invst.
$7.76M
Total Debt
$11.82M
ARYx Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$0.00
N/A
Market Cap/Employee
N/A
N/A
Employees
56
N/A
Net Income
$2.51M
+69.2%
EBITDA
$1.94M
+74.0%
Quarterly Fundamentals
Net Cash
$9.37M
-1012.9%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$5.50M
-26.9%
Short Term Debt
$6.83M
+0.5%
Return on Assets
-2.67%
N/A
Return on Invested Capital
-8.39%
N/A
Free Cash Flow
$4.05M
+40.4%
Operating Cash Flow
$4.05M
+40.4%